Innovative Healthcare Advantage

“Health City Cayman Islands might be one of the disruptors that finally pushes the overly expensive U.S. system to innovate.”

Reference from www.HBR.org  by Vijay Govindarajan and Ravi Ramamurti of the Harvard Business Review Economics & Society section report  “Is This the Hospital That Will Finally Push the Expensive U.S. Health Care System to Innovate?“  June 22, 2018.  

Link to HBR article below:

https://hbr.org/2018/06/is-this-the-hospital-that-will-finally-push-the-expensive-u-s-health-care-system-to-innovate 

With global competition able to forever change other seemingly untouchable industries, will the same happen to U.S. health care? The article discusses Health City Cayman Islands (HCCI) founded by Dr. Devi Shetty who wanted to disrupt the U.S. Health System with his venture.  A great read, highlighting Shetty’s disruptive ideas for reverse engineering quality health outcomes at significant cost savings compared to U.S. health care spending.  Being close to home, yet outside U.S. regulatory boundaries, HCCI could represent a high quality, low cost health care option.

Along with further reading in book (link included below)

Reverse Innovation in Health Care: How to Make Value-Based Delivery Work

INNOVATION & ENTREPRENEURSHIP BOOK

authors Vijay Govindarajan & Ravi Ramamurti

Leaders of the three companies are seeking to reduce healthcare costs and improve quality through innovative approaches…

“We said at the outset that the degree of difficulty is high, and success is going to require an expert’s knowledge, a beginner’s mind, and a long-term orientation,” said Jeff Bezos, founder and CEO of Amazon, in prepared remarks Wednesday. “Atul embodies all three, and we’re starting strong as we move forward in this challenging and worthwhile endeavor.”

quote taken from WSJ Report by

Anna Wilde Mathews

Updated June 20, 2018 5:08 p.m. ET

https://www.wsj.com/articles/amazon-berkshire-and-jpmorgan-pick-ceo-for-new-health-care-company-1529504379

JP Morgan CEO James Dimon along with JP Morgan Healthcare bankers emphasized the partnership’s focus being the benefits and efficiencies brought by a large purchase organization for employees of the three companies.

referenced WSJ Report by Anna Wilde Mathews, Dana Cimilluca & Emily Glazer

Updated Feb. 4, 2018 7:35 p.m. ET

dhttps://www.wsj.com/articles/jpmorgan-to-banking-clients-joint-health-care-venture-is-no-threat-

New tool with technology capable of diagnosing severe stoke by emergency responder in the field, approved by the FDA .  Neural Analytics, Inc. of LA received FDA approval for their Lucid  Robotic System that can diagnosis severe stroke in pre-hospital setting,  allowing patients to be sent to appropriate stroke protocol enabled hospitals and allowing provider hospitals to prepare for rapid treatment upon arrival with with clot busting medication, tPa,  and  other stroke protocol, such as thrombectomy; significantly improving patient outcomes.

Source: www.WSJ.com report by Thomas M. Burton | May 30, 2018.  Link below.

ke-technology-to-identify-worst-cases-gets-fda-approval-1527709670

With the potential for patients, providers and payers to all work from the same record there is significant opportunity to decrease errors, improve efficacy and delivery of care at lower overall cost.

Source: WSJ.com article “How Blockchain Could Help Lower Health Costs: The digital ledger could replace fragmented data systems simplifying record-keeping and improving care”

by Tomio Geron | May 28, 2018. Link below.

https://www.wsj.com/articles/how-blockchain-could-help-lower-health-costs-1527559440